Summary
This prediction ended on 09.09.13 with a price of €83.46. The BUY prediction by DirectorDealer_Intensive finished with a performance of 9.02%. DirectorDealer_Intensive has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Bayer AG | 3.567% | 3.567% | -42.485% | -39.624% |
iShares Core DAX® | -3.429% | 5.085% | 15.455% | 12.600% |
iShares Nasdaq 100 | -6.121% | 0.593% | 16.379% | 27.048% |
iShares Nikkei 225® | -7.364% | 5.479% | 6.970% | -3.061% |
iShares S&P 500 | -4.366% | 2.019% | 18.650% | 32.317% |
Comments by DirectorDealer_Intensive for this prediction
In the thread Bayer AG diskutieren
Director Dealing: Kauf
Director Dealing / Insider Kauf von Börsig, Dr. Clemens (Aufsichtsorgan)
- Handelstag: 05.03.13
- Volumen: 20324 €
- Meldender: Börsig, Dr. Clemens
Wir werten alle Insider Käufe aus. Gemeinsam mit der Universität Innsbruck wurde eine Handelsstrategie auf Basis des Intensive Tradings entwickelt. Mehr Informationen finden Sie im Profil von DirectorDealer_Intensive
.
Director Dealing / Insider Kauf von Schmidt-Kiessling, Michael (Aufsichtsorgan)
- Handelstag: 06.03.13
- Volumen: 20324 €
- Meldender: Schmidt-Kiessling, Michael